PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Flecainide acetate
Presentation Product Chemical substance Chapter Items dispensed
Flecainide 35mg/5ml oral liquid
0203020I0AABKBK
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 37.5mg/5ml oral liquid
0203020I0AABHBH
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 40mg/5ml oral liquid
0203020I0AABCBC
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 4mg/5ml oral liquid
0203020I0AABPBP
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 50mg/5ml oral liquid
0203020I0AAAQAQ
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 5mg/5ml oral liquid
0203020I0AAARAR
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 60mg/5ml oral liquid
0203020I0AABJBJ
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 65mg/5ml oral liquid
0203020I0AABGBG
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 6mg/5ml oral liquid
0203020I0AABDBD
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Flecainide 80mg/5ml oral liquid
0203020I0AABEBE
Flecainide acetate Flecainide acetate Cardiovascular System No data available
Tambocor 150mg/15ml solution for injection ampoules
0203020I0BBABAA
Tambocor Flecainide acetate Cardiovascular System No data available
Tambocor XL 200mg capsules
0203020I0BBADBQ
Tambocor Flecainide acetate Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.